Replies to post #25008 on CytoSorbents Corporation (CTSO)

[hemopure36]

This is why our quarterly revenues are not as important as most here think they are YET. What is important is the company’s potential after FDA approval for any indication. People here cannot seem to see through the one dimensional idea of quarterly revenues at this stage. It’s not reasonable to concentrate on the traditional metrics used to evaluate mature biotechs that have FDA approval. There is enormous potential here, in my opinion, and I’m pleased they don’t send out fluff PR’s twice a week, as some here seem to want.